Next Article in Journal
Enhanced Visible-Light Photocatalytic Activities of CeVO4-V2O3 Composite: Effect of Ethylene Glycol
Next Article in Special Issue
Transition Metal-Free Synthesis of 3-Acylquinolines through Formal [4+2] Annulation of Anthranils and Enaminones
Previous Article in Journal
Engineering Strategies for Efficient Bioconversion of Glycerol to Value-Added Products by Yarrowia lipolytica
Previous Article in Special Issue
Four-Component Synthesis of 9H-Pyrimido[4,5-b]indoles Using Ammonium Iodide as the Nitrogen Source
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Catalysts
Volume 13
Issue 4
10.3390/catal13040658
catalysts-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

One-Pot Synthesis of Benzoxazole/Benzothiazole-Substituted Esters by Michael Addition: A Selective Construction of C-N/C-S Bonds

by
Zhi-Ying Gong
1,†,
Cheng-Li Yang
1,†,
Dan Wang
1,
Lang Huang
1 and
Zhi-Bing Dong
1,2,3,*
1
School of Chemistry and Environmental Engineering, Wuhan Institute of Technology, Wuhan 430205, China
2
Key Laboratory of Green Chemical Process, Ministry of Education, Wuhan Institute of Technology, Wuhan 430205, China
3
School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Catalysts 2023, 13(4), 658; https://doi.org/10.3390/catal13040658
Submission received: 25 February 2023 / Revised: 20 March 2023 / Accepted: 24 March 2023 / Published: 27 March 2023
(This article belongs to the Special Issue Catalytic Annulation Reactions)
Browse Figures
Versions Notes

Abstract

:
An efficient and convenient synthesis of benzoxazole/benzothiazole-substituted esters in a one-pot strategy is reported. In this investigation, a selective construction of C-N and C-S bonds via simple addition is performed. Thus, using substituted 2-aminophenols/2-aminobenzenethiols, TMTD (tetramethylthiuram disulfide) and α,β-unsaturated esters as starting substrates, C-N and C-S bonds can be selectively constructed by means of the Michael addition reaction. This protocol features high selectivity, high atomic economy, mild conditions, good functional tolerance and good to excellent yields, showing the potential value for the preparation of some biologically and pharmaceutically active compounds.

Graphical Abstract

1. Introduction

Compounds containing C-N/C-S bonds have become a key part in organic synthesis, biomedicine, material chemistry and industrial manufacturing [1,2,3,4,5,6,7,8,9,10,11,12,13]. Many heterocyclic compounds bearing C-N/C-S bonds are indispensable in pharmaceutical chemistry due to their unique biological and pharmaceutical activities (Figure 1). These compounds can be used as an anti-inflammatory (a) [14], a heat shock protein 90 (Hsp 90) an inhibitor (b) [15], a botanical fungicide or insecticide (c) [16], a CpIMPDH inhibitor (d) [17], a CCR3 selective antagonist (e) [18], a lipoxygenase inhibitor (f) [19], an anticancer agent (g) [20] and an antinematode drug (h) [21]. Therefore, the construction of the C-N bond and the C-S bond has aroused the interest of the organic chemistry community.
So far, various methods for constructing C-N/S bonds have been reported (Scheme 1). Bolm [22], Buchwald [23], Chen [24] and Biswasa [25] realized the construction of the C-N bond by using aryl halides or alcohols to react with nitrogen-containing heterocyclic compounds. The most traditional method to form the C-S bond is the coupling reaction between thiols and aryl halides [26,27,28,29,30,31]. The Sokolova [32] and Ma [33] group completed the construction of the C-S bond under base conditions. In addition, Yuan and Hajra [34,35] used phenylhydrazine and phenylthiophenol as starting materials to obtain various compounds containing a C-S bond via visible-light-mediated synthesis or aerobic-oxidative coupling. Our laboratory and other groups [36,37,38] also completed the construction of the C-S bond through the Chan-Lam coupling reaction. To the best of our knowledge, the selective construction of C-N/C-S bonds has rarely been reported [39,40]. Though, efficient, the previously reported methods for the construction of C-N/C-S bonds involved the use of toxic, foul-smelling, and expensive reagents, transition metals as catalysts, a high reaction temperature, a long reaction time, as well as low conversion, which limited the application of these methods in pharmaceutical synthesis. Thus, it is still desirable to develop efficient protocols for the selective construction of C-N/C-S bonds, especially the ones using a tandem or one-pot synthesis strategy.
As part of our long-term interest in constructing various C-X (X = O, S, N, P) bonds and studying the synthesis of benzoheterocyclic compounds [41,42,43,44,45], we report here an effective and practical method for the selective formation of C-N/C-S bonds by Michael addition reactions, starting from substituted 2-aminophenols/2-aminobenzenethiols and TMTD (tetramethylthiuram disulfide) with α,β-unsaturated esters in a one-pot strategy (Scheme 2, the present study).

2. Results and Discussion

For our initial study, we chose 2-aminophenol (1a), tetramethylthiuram disulfide (TMTD) and ethyl acrylate (2a) as the starting materials for the model reaction to explore the optimal reaction conditions (Table 1). Our laboratory has previously made good progress in the synthesis of benzoheterocyclic compounds. The reaction conditions for the first step to produce 2-aminophenols were slightly adjusted based on our previous work [41,42,43,44,45], and our attempts were focused on the second step (the Michael addition reaction). Using CuI as the catalyst and Et3N as the base in the initial attempt, the ideal product 3aa was obtained with a 19% yield of EtOH (Entry 1, Table 1). Next we tried other catalysts and found that the catalytic effect of CuI was slightly better (Entries 1–4, Table 1). We were surprised to find that the yield was greatly improved when DMF was used as the solvent (Entry 5, Table 1), and the result was better without adding metal salt as the catalyst (entry 6, Table 1). The screening of bases and reaction temperature showed that Et3N was the best base and 80 °C was the optimal temperature (entries 7–12, Table 1). Furthermore, the loading of the base and the type of solvent were also investigated, and the results are shown in entries 13–16, Table 1. The optimal reaction conditions are summarized in Entry 10, Table 1. It is worth noting that the model reaction in Table 1 always produced the by-product 3aa’ in traces which formed the C-S bond in the additional step.
According to the optimal conditions obtained above, a variety of related substrates are explored, and the results are presented in Table 2. First, the reaction effect of various substituted 2-aminophenols and ethyl acrylate was investigated, and the experimental results showed that 2-aminophenols with either electron-withdrawing groups (-Br, -Cl) or electron-donating groups (-CH3, -tBu) could react readily with ethyl acrylate to give the desired products with a moderate to good yield (3aa–3ah). When tert-butyl acrylate and cyclohexyl acrylate were used to react with various substituted 2-aminophenols, the reaction also worked well and provided the expected products (3ai–3av) readily. When 2-amino-3-methylphenol was used as the starting material to react with ethyl acrylate, tert-butyl acrylate and cyclohexyl acrylate, the compounds (3ah, 3aj, 3ar) could only be obtained in 28%, 29% and 36% yields, respectively, which might be due to the steric hindrance.
To further determine the structure of the target products, we performed an X-ray diffraction analysis of 3ai (CCDC: 2152821, Figure 2) to show the exact C-N bond formation of the product.
The above optimal reaction conditions were also applicable to the reactions between various substituted 2-aminobenzenethiols (1) and α,β-unsaturated esters (2). However, this reaction would give the C-S formation products (all oily) as major ones via Michael addition, and the C-N formation products were obtained in traces. Thus, under standard conditions, a variety of substituted 2-aminobenzenethiols (1) and TMTD could react with ethyl acrylate, tert-butyl acrylate and cyclohexyl acrylate, smoothly, giving the target products with a moderate yield (5aa–5ag, Table 3). To determine the detailed structure of the target product, the X-ray diffraction analysis of by-product 5ag’ (CCDC: 2152790, Figure 3) was performed, showing the existence of the C-N bond formation, which could further indicate the C-S bond formation of the major product 5ag.

3. Conclusions

In summary, we developed an efficient and convenient one-pot method to selectively construct C-N and C-S bonds by a simple Michael addition. Using substituted 2-aminophenols/2-aminobenzenethiols, TMTD (tetramethylthiuram disulfide) and α,β-unsaturated esters as starting substrates, a variety of benzoxazole/benzothiazole substituted esters were obtainedwithout problem, forming C-N and C-S bonds selectively. This strategy features high selectivity, high atomic economy, mild conditions, good functional tolerance. and good yields, showing its potential value for the preparation of some biologically and pharmaceutically active compounds.

4. Experimental Section

General Information. All starting materials were commercially purchased. Yields refer to isolated compounds estimated to be >95% pure as determined by 1H NMR and capillary GC analysis. NMR spectra were recorded on a Bruker AM400 or AM 600 NMR instrument in CDCl3 using TMS as an internal standard. Chemical shifts are given in ppm, and coupling constants (J) are given in Hz. All melting points were determined on a RY-1G melting point instrument without correction. High-resolution mass spectra (HRMS) were recorded on a Angilent 6545LC/Q-TOF mass instrument (ESI). TLC was performed using aluminum plates coated with SiO2 (Merck 60, F-254) and visualized with UV light at 254 nm. Column chromatography was performed on silica gel (200–300 mesh) with PE (petroleum ether)-EA (ethyl acetate) as an eluent.
General procedure for the synthesis of desired products forming C-N bonds (3aa–3av).
A mixture of substituted 2-aminophenols (1, 0.5 mmol) and tetramethylthiuram disulfide (TMTD, 0.3 mmol) in DMF (2 mL) was stirred at 80 °C for 3 h until the substrates completely disappeared. Subsequently, the sealed tube was cooled to room temperature. 2 (ethyl acrylate, tert-butyl acrylate, or cyclohexyl acrylate, 1.0 mmol) and Et3N (2.0 eq.) were added, and the mixture was stirred at 80 °C for 6 h. After the reaction was completed, it was quenched with saturated NH4Cl, and the crude solution was separated after diluting with ethyl acetate and dried-over anhydrous Na2SO4. The solvent was removed in a vacuum to obtain the crude product, which was further separated and purified by column chromatography to give the desired products (3aa–3av).
General procedure for the synthesis of desired products forming C-S bonds (5aa–5ag).
A mixture of substituted 2-aminobenzenethiols (4, 0.5 mmol) and tetramethylthiuram disulfide (TMTD, 0.3 mmol) in DMF (2 mL) was stirred at 80 °C for 3 h until the substrates completely disappeared. Subsequently, the sealed tube was cooled to room temperature, 2 (ethyl acrylate, tert-butyl acrylate, or cyclohexyl acrylate, 1.0 mmol) and Et3N (2.0 eq.) were added, and the mixture was stirred at 80 °C for 6 h. After the reaction was completed, it was quenched with saturated NH4Cl, and the crude solution was separated after diluting with ethyl acetate and dried over anhydrous Na2SO4. The solvent was removed in a vacuum to obtain the crude product, which was further separated and purified by column chromatography to give the desired products (5aa–5ag).
ethyl 3-(2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3aa): The target product 3aa (106.8 mg, 85%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:10). 1H NMR (400 MHz, CDCl3) δ ppm: 7.27–7.14 (m, 4H), 4.37 (t, J = 6.8 Hz, 2H), 4.02 (q, J = 7.2 Hz, 2H), 2.88 (t, J = 6.8, 2H), 1.11 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.0, 169.8, 146.1, 130.8, 123.9, 123.3, 109.3, 109.0, 60.1, 40.4, 30.3, 13.0. HRMS (ESI) m/z [M + H]+ Calcd for C12H14NO3S+ 252.0689; Found 252.0682.
ethyl 3-(5-bromo-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ab): The target product 3ab (138.7 mg, 84%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 72–74 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.36 (d, J = 2.0, 1H), 7.29–7.25 (m, 1H), 7.12 (d, J = 8.4 Hz, 1H), 4.32 (t, J = 6.8, 2H), 4.05 (q, J = 7.1 Hz, 2H), 1.14 (t, J = 7.0 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.3, 169.6, 145.1, 132.3, 126.1, 116.8, 112.2, 110.4, 60.2, 40.6, 30.2, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C12H13BrNO3S+ 329.9794; Found 329.9797.
ethyl 3-(6-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ac): The target product 3ac (108.8 mg, 82%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 58–60 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.10–7.01 (m, 3H), 4.35 (t, J = 6.8 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 2.87 (t, J = 8.6, 2H), 2.35 (s, 3H), 1.13 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 178.9, 169.9, 146.4, 138.7, 133.8, 128.6, 124.6, 109.8, 108.5, 60.1, 40.4, 30.3, 20.4, 13.0. HRMS (ESI) m/z [M + H]+ Calcd for C13H16NO3S+ 266.0845; Found 266.0842.
ethyl 3-(5-chloro-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ad): The target product 3ad (111.4 mg, 78%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 58–60 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.23 (s, 1H), 7.18–7.08 (m, 2H), 4.32 (t, J = 6.6, 2H), 4.04 (q, J = 7.2, 2H), 2.88 (t, J = 6.6 Hz, 2H), 1.14 (t, J = 7.0 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.4, 169.6, 144.6, 132.0, 129.6, 123.2, 109.9, 109.5, 60.2, 40.7, 30.2, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C12H13ClNO3S+ 286.0299; Found 286.0294.
ethyl 3-(5-(tert-butyl)-2-mercaptobenzo[d]oxazol-3(2H)-yl)propanoate (3ae): The target product 3ae (135.3 mg, 88%) was synthesized as a yellow oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.23–7.13 (m, 3H), 4.40 (t, J = 6.8 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 2.86 (t, J = 6.8, 2H), 1.28 (s, 9H), 1.10 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.3, 169.9, 147.8, 144.2, 130.5, 120.5, 108.5, 105.9, 60.0, 40.3, 34.1, 30.6, 30.5, 13.0. HRMS (ESI) m/z [M + H]+ Calcd for C16H22NO3S+ 308.1315; Found 308.1316.
ethyl 3-(6-chloro-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3af): The target product 3af (75.7 mg, 53%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 90–92 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.27 (s, 1H), 7.20 (q, J = 9.9 Hz, 2H), 4.34 (t, J = 6.4 Hz, 2H), 4.03 (q, J = 7.1, 2H), 2.89 (t, J = 6.4 Hz, 2H), 1.13 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.1, 169.9, 146.2, 129.9, 129.1, 124.1, 109.9, 109.7, 60.2, 40.6, 30.2, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C12H13ClNO3S+ 286.0299; Found 286.0297.
ethyl 3-(5-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ag): The target product 3ag (92.9 mg, 70%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.20 (d, J = 8.9 Hz, 1H), 7.04 (d, J = 7.2 Hz, 2H), 4.42 (t, J = 6.9, 2H), 4.12 (q, J = 7.2, 2H), 2.94 (t, J = 6.9 Hz, 2H), 2.44 (s, 3H), 1.20 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.2, 169.8, 144.4, 134.2, 130.8, 124.0, 109.1, 108.9, 60.1, 40.3, 30.3, 20.5, 13.0. HRMS (ESI) m/z [M + H]+ Calcd for C13H16NO3S+ 266.0845; Found 266.0851.
ethyl 3-(4-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ah): The target product 3ah (37.1 mg, 28%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 70–72 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.19 (d, J = 8.0 Hz, 1H), 7.12 (t, J = 7.8, 1H), 7.04 (d, J = 7.6, 1H), 4.68 (t, J = 7.8, 2H), 4.15 (q, J = 7.1 Hz, 2H), 2.93 (t, J = 7.8, 2H), 2.63 (s, 3H), 1.23 (t, J = 7.1, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.4, 169.3, 146.4, 128.7, 127.0, 123.2, 119.7, 107.5, 60.1, 41.6, 31.2, 16.7, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C13H16NO3S+ 266.0845; Found 266.0843
tert-butyl 3-(2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ai): The target product 3ai (120.1 mg, 86%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 88–90 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.28–7.15 (m, 4H), 4.35 (t, J = 6.9 Hz, 2H), 2.78 (t, J = 6.9 Hz, 2H), 1.31 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.1, 169.0, 146.1, 130.8, 123.9, 123.3, 109.3, 109.1, 80.6, 40.5, 31.5, 27.0. HRMS (ESI) m/z [M + H]+ Calcd for C14H18NO3S+ 280.1002; Found 280.1006.
tert-butyl 3-(4-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3aj): The target product 3aj (42.5 mg, 29%) was synthesized as a yellow oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.20 (d, J = 7.6 Hz, 1H), 7.13 (t, J = 7.8 Hz, 1H), 7.04 (d, J = 7.6 Hz, 1H), 4.65 (t, J = 7.9 Hz, 2H), 2.84 (t, J = 8.0 Hz, 2H), 2.63 (s, 3H), 1.43 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.3, 168.5, 146.4, 128.7, 127.0, 123.2, 119.8, 107.5, 80.7, 41.8, 32.4, 27.3, 16.7. HRMS (ESI) m/z [M + H]+ Calcd for C15H20NO3S+ 294.1158; Found 294.1156.
tert-butyl 3-(6-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ak): The target product 3ak (130.6 mg, 89%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 66–68 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.13 (d, J = 7.8 Hz, 2H), 7.08 (d, J = 8.4 Hz, 1H), 4.37 (t, J = 6.9 Hz, 2H), 2.82 (t, J = 6.9 Hz, 2H), 2.41 (s, 3H), 1.38 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 178.9, 169.1, 146.4, 133.8, 128.6, 124.5, 109.7, 108.6, 80.6, 40.5, 31.5, 27.0, 20.4. HRMS (ESI) m/z [M + H]+ Calcd for C15H20NO3S+ 294.1158; Found 294.1163.
tert-butyl 3-(5-(tert-butyl)-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3al): The target product 3al (122.4 mg, 73%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.29–7.26 (m, 2H), 7.24 (d, J = 9.0 Hz, 1H), 4.44 (t, J = 6.9 Hz, 2H), 2.84 (t, J = 6.9 Hz, 2H), 1.38 (s, 9H), 1.36 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 180.4, 170.3, 148.8, 145.2, 131.6, 121.5, 109.6, 107.1, 81.6, 41.4, 35.1, 32.6, 31.6, 28.0. HRMS (ESI) m/z [M + H]+ Calcd for C18H26NO3S+ 336.1628; Found 336.1626.
tert-butyl 3-(5-bromo-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3am): The target product 3am (150.5 mg, 84%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 136–138 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.43 (d, J = 1.8 Hz, 1H), 7.35 (dd, J = 8.6, 1.8 Hz, 1H), 7.19 (d, J = 8.6 Hz, 1H), 4.36 (t, J = 6.8 Hz, 2H), 2.82 (t, J = 6.8 Hz, 2H), 1.40 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.3, 168.9, 145.1, 132.2, 126.1, 116.8, 112.2, 110.4, 80.9, 40.8, 31.5, 27.0. HRMS (ESI) m/z [M + H]+ Calcd for C14H17BrNO3S+ 358.0107; Found 358.0112.
tert-butyl 3-(6-chloro-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3an): The target product 3an (109.8 mg, 70%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 88–90 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.27 (d, J = 1.7 Hz, 1H), 7.21 (dd, J = 8.5, 1.7 Hz, 1H), 7.17 (d, J = 8.5 Hz, 1H), 4.31 (t, J = 6.6 Hz, 2H), 2.78 (t, J = 6.6 Hz, 2H), 1.32 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.1, 169.1, 146.2, 129.8, 129.0, 124.1, 109.9, 109.7, 80.7, 40.7, 31.4, 27.0. HRMS (ESI) m/z [M + H]+ Calcd for C14H17ClNO3S+ 314.0612; Found 314.0606.
cyclohexyl 3-(2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ao): The target product 3ao (135.9 mg, 89%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.26–7.13 (m, 4H), 4.68–4.60 (m, 1H), 4.37 (t, J = 6.8 Hz, 2H), 4.79–4.71 (t, J = 6.8 Hz, 2H), 3.47 (t, J = 6.8 Hz, 2H), 2.86 (t, J = 6.7 Hz, 2H), 1.71–1.64 (m, 2H), 1.61–1.54 (m, 2H), 1.46–1.14 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.1, 169.4, 146.2, 130.9, 123.9, 123.3, 109.3, 109.1, 72.7, 40.5, 30.7, 30.4, 24.2, 22.6. HRMS (ESI) m/z [M + H]+ Calcd for C16H20NO3S+ 306.1158; Found 306.1155.
cyclohexyl 3-((6-methylbenzo[d]oxazol-2-yl)thio)propanoate (3ap): The target product 3ap (110.2 mg, 69%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.45 (d, J = 8.1 Hz, 1H), 7.23 (s, 1H), 7.08 (dd, J = 8.1, 0.8 Hz, 1H), 4.85–4.78 (m, 1H), 3.52 (t, J = 7.1 Hz, 2H), 2.90 (t, J = 6.9 Hz, 2H), 2.45 (s, 3H), 1.90–1.81 (m, 2H), 1.76–1.67 (m, 2H), 1.54–1.23 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 169.8, 162.6, 151.2, 138.7, 133.3, 124.3, 116.7, 109.2, 72.4, 33.7, 30.6, 26.2, 24.3, 22.7, 20.6. HRMS (ESI) m/z [M + H]+ Calcd for C17H22NO3S+ 320.1315; Found 320.1316.
cyclohexyl 3-(5-(tert-butyl)-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3aq): The target product 3aq (126.5 mg, 70%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.20 (dd, J = 8.5, 1.7 Hz, 1H), 7.18–7.14 (m, 2H), 4.68–4.59 (m, 1H), 4.39 (t, J = 6.8 Hz, 2H), 2.83 (t, J = 6.8 Hz, 2H), 1.67–1.53 (m, 4H), 1.46–1.06 (m, 16H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.2, 169.4, 147.8, 144.2, 130.5, 120.5, 108.5, 106.0, 72.5, 40.4, 34.1, 30.8, 30.6, 30.4, 24.2, 22.6. HRMS (ESI) m/z [M + H]+ Calcd for C20H28NO3S+ 362.1784; Found 362.1777.
cyclohexyl 3-(4-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3ar): The target product 3ar (57.5 mg, 36%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 78–80 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.20 (d, J = 7.7 Hz, 1H), 7.13 (t, J = 7.8 Hz, 1H), 7.04 (d, J = 7.6 Hz, 1H), 4.82–4.75 (m, 1H), 4.68 (t, J = 7.8 Hz, 2H), 2.92 (t, J = 7.8 Hz, 2H), 2.63 (s, 3H), 1.85–1.78 (m, 2H), 1.73–1.65 (m, 2H), 1.56–1.26 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.3, 168.7, 146.4, 128.7, 127.0, 123.2, 119.8, 107.5, 72.6, 41.7, 31.6, 30.5, 24.3, 22.6, 16.7. HRMS (ESI) m/z [M + H]+ Calcd for C17H22NO3S+ 320.1315; Found 320.1313.
cyclohexyl 3-(5-bromo-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3as): The target product 3as (153.7 mg, 80%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 96–98 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.42 (d, J = 1.8 Hz, 1H), 7.34 (dd, J = 8.6, 1.8 Hz, 1H), 7.18 (d, J = 8.6 Hz, 1H), 4.77–4.68 (m, 1H), 4.37 (t, J = 6.6 Hz, 2H), 2.91 (t, J = 6.6 Hz, 2H), 1.82–1.73 (m, 2H), 1.69–1.62 (m, 2H), 1.55–1.21 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.3, 169.2, 145.1, 132.3, 126.1, 116.8, 112.3, 110.4, 72.9, 40.7, 30.6, 30.5, 24.2, 22.7. HRMS (ESI) m/z [M + H]+ Calcd for C16H19BrNO3S+ 384.0264; Found 384.0266.
cyclohexyl 3-(6-chloro-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3at): The target product 3at (149.5 mg, 88%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 86–88 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.27 (d, J = 1.6 Hz, 1H), 7.22 (dd, J = 8.5, 1.7 Hz, 1H), 7.18 (d, J = 8.5 Hz, 1H), 4.68–4.60 (m, 1H), 4.33 (t, J = 6.5 Hz, 2H), 2.87 (t, J = 6.5 Hz, 2H), 1.72–1.65 (m, 2H), 1.62–1.55 (m, 2H), 1.46–1.14 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.1, 169.4, 146.2, 129.9, 129.0, 124.1, 109.9, 109.7, 72.8, 40.7, 30.5, 30.4, 24.2, 22.6. HRMS (ESI) m/z [M + H]+ Calcd for C16H19ClNO3S+ 340.0769; Found 340.0776.
cyclohexyl 3-(5-chloro-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3au): The target product 3au (95.2 mg, 56%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 110–112 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.30 (d, J = 1.6 Hz, 1H), 7.24 (d, J = 8.6 Hz, 1H), 7.20 (dd, J = 8.6, 1.8 Hz, 1H), 4.77–4.69 (m, 1H), 4.38 (t, J = 6.6 Hz, 2H), 2.93 (t, J = 6.6 Hz, 2H), 1.82–1.73 (m, 2H), 1.72–1.63 (m, 2H), 1.52–1.20 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.5, 169.2, 144.6, 132.0, 129.8, 123.2, 109.9, 109.5, 72.9, 40.7, 30.6, 30.5, 24.2, 22.7. HRMS (ESI) m/z [M + H]+ Calcd for C16H19ClNO3S+ 340.0769; Found 340.0766.
cyclohexyl 3-(5-methyl-2-thioxobenzo[d]oxazol-3(2H)-yl)propanoate (3av): The target product 3av (138.9 mg, 87%) was synthesized as a white solid, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). mp: 98–100 °C. 1H NMR (400 MHz, CDCl3) δ ppm: 7.19 (d, J = 8.2 Hz, 1H), 7.06–7.00 (m, 2H), 4.76–4.69 (m, 1H), 4.41 (t, J = 6.9 Hz, 2H), 2.91 (t, J = 6.9 Hz, 2H), 2.43 (s, 3H), 1.80–1.72 (m, 2H), 1.69–1.63 (m, 2H), 1.54–1.19 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 179.2, 169.3, 144.4, 134.1, 130.8, 124.0, 109.2, 108.8, 72.7, 40.4, 30.7, 30.5, 24.2, 22.6, 20.5. HRMS (ESI) m/z [M + H]+ Calcd for C17H22NO3S+ 320.1315; Found 320.1321.
ethyl 3-(benzo[d]thiazol-2-ylthio)propanoate (5aa): The target product 5aa (88.2 mg, 66%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:10). 1H NMR (400 MHz, CDCl3) δ ppm: 7.48 (dd, J = 8.0, 4.0 Hz, 1H), 7.44–7.39 (m, 1H), 7.34–7.27 (m, 2H), 5.00 (t, J = 4.0, 2H), 4.12 (q, J = 8.0 Hz, 2H), 2,87 (t, J = 8.0 Hz, 2H), 1.21 (t, J = 8.0 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 186.6, 169.8, 156.5, 134.2, 127.9, 113.4, 112.0, 104.7, 60.1, 54.9, 41.0, 30.3, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C12H13NO2S2+ 268.0460; Found 268.0463.
tert-butyl 3-(benzo[d]thiazol-2-ylthio)propanoate (5ab): The target product 5ab (104.9 mg, 71%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.30 (d, J = 8.0 Hz, 1H), 7.23 (d, J = 7.6, 1H), 7.18–7.09 (m, 2H), 4.49 (t, J = 7.6, 2H), 2.60 (t, J = 7.6 Hz, 2H), 1.25 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 188.1, 169.0, 140.2, 126.7, 126.0, 123.8, 120.4, 111.5, 80.5, 41.0, 31.4, 27.0. HRMS (ESI) m/z [M + H]+ Calcd for C14H18NO2S2+ 296.0773; Found 296.0771.
cyclohexyl 3-(benzo[d]thiazol-2-ylthio)propanoate (5ac): The target product 5ac (99.7 mg, 62%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.40 (d, J = 7.8 Hz, 1H), 7.34 (t, J = 7.2 Hz, 1H), 7.28–7.18 (m, 2H), 4.71–4.64 (m, 1H), 4.61 (t, J = 7.4 Hz, 2H), 2.78 (t, J = 7.4 Hz, 2H), 1.73–1.57 (m, 4H), 1.46–1.1.13 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 188.1, 169.2, 140.2, 126.7, 126.0, 123.8, 120.4, 111.5, 72.5, 41.0, 30.6, 30.4, 24.3, 22.6. HRMS (ESI) m/z [M + H]+ Calcd for C16H20NO2S2+ 322.0930; Found 322.0935.
ethyl 3-((5-chlorobenzo[d]thiazol-2-yl)thio)propanoate (5ad): The target product 5ad (66.4 mg, 44%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:15). 1H NMR (400 MHz, CDCl3) δ ppm: 7.31 (d, J = 8.4 Hz, 1H), 7.27 (d, J = 2.0 Hz, 1H), 7.21 (dd, J = 8.4, 1.8 Hz, 1H), 4.58 (t, J = 7.4, 2H), 4.09 (q, J = 7.2 Hz, 2H), 2.81 (t, J = 7.2 Hz, 2H), 1.18 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 188.9, 169.6, 141.1, 132.4, 124.9, 124.0, 121.0, 111.7, 60.2, 401.1, 30.2, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C12H13ClNO2S2+ 302.0071; Found 302.0068.
tert-butyl 3-((5-chlorobenzo[d]thiazol-2-yl)thio)propanoate (5ae): The target product 5ae (100.6 mg, 61%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.35 (d, J = 8.4 Hz, 1H), 7.31 (d, J = 1.6 Hz, 1H), 7.26–7.23 (m, 1H), 4.59 (t, J = 7.4 Hz, 2H), 2.74 (t, J = 7.4 Hz, 2H), 1.41 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 188.1, 169.8, 140.2, 126.7, 126.0, 123.8, 120.4, 111.4, 60.1, 40.9, 30.3, 13.1. HRMS (ESI) m/z [M + H]+ Calcd for C14H17ClNO2S2+ 330.0384; Found 330.0386.
cyclohexyl 3-((5-chlorobenzo[d]thiazol-2-yl)thio)propanoate (5af): The target product 5af (99.7 mg, 62%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.39 (d, J = 8.4 Hz, 1H), 7.35 (s, 1H), 7.22–7.17 (m, 1H), 4.74–4.66 (m, 1H), 4.64 (t, J = 7.2 Hz, 2H), 2.86 (t, J = 7.2 Hz, 2H), 1.87–1.77 (m, 2H), 1.74–1.65 (m, 2H), 1.52–1.18 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ ppm: 188.8, 169.1, 141.1, 132.4, 124.9, 124.0, 121.0, 111.7, 72.7, 41.2, 30.6, 30.5, 24.3, 22.7. HRMS (ESI) m/z [M + H]+ Calcd for C16H19ClNO2S2+ 356.0540; Found 356.0536.
tert-butyl 3-((6-methoxybenzo[d]thiazol-2-yl)thio)propanoate (5ag): The target product 5ag (113.9 mg, 70%) was synthesized as a colorless oil, and purified by column chromatography (ethyl acetate/petroleum ether = 1:7). 1H NMR (400 MHz, CDCl3) δ ppm: 7.16 (d, J = 8.8 Hz, 1H), 6.93–6.87 (m, 2H), 4.53 (t, J = 7.4 Hz, 2H), 3.75 (s, 3H), 2.69 (t, J = 7.4 Hz, 2H), 1.34 (s, 9H). 13C NMR (100 MHz, CDCl3) δ ppm: 186.1, 168.5, 156.0, 133.8, 127.4, 112.9, 111.6, 104.1, 80.0, 54.4, 40.6, 30.9, 26.5. HRMS (ESI) m/z [M + H]+ Calcd for C15H20NO3S2+ 326.0879; Found 326.0871.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/catal13040658/s1, Characterization data for all products, X-ray diffraction analysis of compound 3ai and 5ag’, 1H-NMR and 13C-NMR spectra of all products. Deposition Numbers 2152790 (for 5ag’), 2152821 (for 3ai) contain the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fachinformationszentrum Karlsruhe “http://www.ccdc.cam.ac.uk/structures”.

Author Contributions

Methodology, Z.-Y.G.; writing—review and editing, Z.-Y.G. and C.-L.Y.; methodology, D.W.; review and editing, L.H.; supervision, Z.-B.D.; project administration, Z.-B.D. All authors have read and agreed to the published version of the manuscript.

Funding

The financial support from the Open Research Fund of School of Chemistry and Chemical Engineering, Henan Normal University (2020ZD02), the Natural Science Foundation of Henan Province (232300421126) is greatly appreciated.

Data Availability Statement

Data supporting reported results can be found in Supplementary Materails.

Acknowledgments

Z.-Y.G. is thankful for the support of Postgraduate Innovation Foundation from Wuhan Institute of Technology.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Huang, W.; Yang, G.F. Microwave-Assisted, One-Pot Syntheses and Fungicidal Activity of Polyfluorinated 2-Benzylthiobenzothiazoles. Bioorg. Med. Chem. 2006, 14, 8280–8285. [Google Scholar] [CrossRef] [PubMed]
  2. Singh, S.P.; Segal, S. Study of Fungicidal Activities of Some Benzothiazoles. Indian J. Chem. 1988, 27B, 941–943. [Google Scholar]
  3. Akhtar, T.; Hameed, S.; Al-Masoudi, N.A.; Loddo, R.; Colla, P. In Vitro Antitumor and Antiviral Activities of New Benzothiazole and 1, 3, 4-Oxadiazole-2-Thione Derivatives. Acta Pharm. 2008, 58, 135–149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Huang, S.T.; Hsei, I.J.; Chen, C. Synthesis and Anticancer Evaluation of Bis (Benzimidazoles), Bis (Benzoxazoles), and Benzothiazoles. Bioorg. Med. Chem. 2006, 14, 6106–6119. [Google Scholar]
  5. Palmer, P.J.; Trigg, R.B.; Warrington, J.V. Benzothiazolines as Antituberculous Agents. J. Med. Chem. 1971, 14, 248–251. [Google Scholar] [CrossRef]
  6. Rao, A.J.; Rao, P.V.; Rao, V.K.; Mohan, C.; Raju, C.N.; Reddy, C.S. Microwave Assisted One-Pot Synthesis of Novel a-Aminophosphonates and Their Biological Activity. Bull. Korean Chem. Soc. 2010, 31, 1863–1868. [Google Scholar] [CrossRef] [Green Version]
  7. Singh, M.; Singh, S.K.; Gangwar, M.; Nath, G.; Singh, S.K. Design, Synthesis and Mode of Action of Some Benzothiazole Derivatives Bearing an Amide Moiety as Antibacterial Agents. RSC Adv. 2014, 4, 19013–19023. [Google Scholar] [CrossRef]
  8. Suresh, C.H.; Rao, J.V.; Jayaveera, K.N.; Subudhi, S.K. Synthesis and Anthelminitc Activity of 3 (2-Hydrazino Benzothiazoles)-Substituted Indole-2-One. Int. Res. J. Pharm. 2011, 2, 257–261. [Google Scholar]
  9. Reddy, P.; Lin, Y.; Chang, H. Synthesis of Novel Benzothiazole Compounds with an Extended Conjugated System. Arkivoc 2007, 16, 113–122. [Google Scholar] [CrossRef]
  10. Heo, Y.; Song, Y.S.; Kim, B.T.; Heo, J.N. A Highly Regioselective Synthesis of 2-Aryl-6-Chlorobenzothiazoles Employing Microwave-Promoted Suzuki-Miyaura Coupling Reaction. Tetrahedron Lett. 2006, 47, 3091–3094. [Google Scholar] [CrossRef]
  11. Azam, M.A.; Suresh, B. Biological Activities of 2-Mercaptobenzothiazole Derivatives: A Review. Sci. Pharm. 2012, 80, 789–824. [Google Scholar] [CrossRef] [Green Version]
  12. Dumas, J.; Brittelli, D.; Chen, J.; Dixon, B.; Hatoum-Mokdad, H.; Konig, G.; Sibley, R.; Witowsky, J.; Wong, S. Synthesis and Structure Activity Relationships of Novel Small Molecule Cathepsin D Inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 2531–2536. [Google Scholar] [CrossRef]
  13. Pejin, B.; Iodice, C.; Tommonaro, G.; Rosa, S.D. Synthesis and Biological Activities of Thio-Avarol Derivatives. J. Nat. Prod. 2008, 71, 1850–1853. [Google Scholar] [CrossRef]
  14. Han, Y.; Dong, W.; Guo, Q.Q.; Li, X.F.; Huang, L.J. The Importance of Indole and Azaindole Scaffold in the Development of Antitumor Agents. Eur. J. Med. Chem. 2020, 203, 112506. [Google Scholar] [CrossRef] [PubMed]
  15. Zhang, L.; Fan, J.; Vu, K.; Hong, K.; Le Brazidec, J.Y.; Shi, J.; Biamonte, M.; Busch, D.J.; Lough, R.E.; Grecko, R.; et al. 7′-Substituted Benzothiazolothio-and Pyridinothiazolothio-Purines as Potent Heat Shock Protein 90 Inhibitors. J. Med. Chem. 2006, 49, 5352–5362. [Google Scholar] [CrossRef] [PubMed]
  16. Zhi, X.Y.; Jiang, L.Y.; Li, T.; Song, L.L.; Wu, L.J.; Cao, H.; Yang, C. Natural Product-Based Semisynthesis and Biological Evaluation of Thiol/Amino-Michael Adduct of Xanthatin Derived from Xanthium Strumarium as Potential Pesticidal Agents. Bioorg. Chem. 2020, 97, 103696. [Google Scholar] [CrossRef]
  17. Gorla, S.K.; Kavitha, M.; Zhang, M.; Chin, J.E.; Liu, X.; Striepen, B.; Makowska-Grzyska, M.; Kim, Y.; Joachimiak, A.; Hedstrom, L.; et al. Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium Parvum Inosine 5′-Monophosphate Dehydrogenase. J. Med. Chem. 2013, 56, 4028–4043. [Google Scholar] [CrossRef] [Green Version]
  18. Naya, A.; Kobayashi, K.; Ishikawa, M.; Ohwaki, K.; Saeki, T.; Noguchi, K.; Ohtake, N. Discovery of a Novel CCR3 Selective Antagonist. Bioorg. Med. Chem. Lett. 2001, 11, 1219–1223. [Google Scholar] [CrossRef]
  19. Choudhary, A.N.; Kumar, A.; Juyal, V. Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors. Mini-Rev. Med. Chem. 2010, 10, 705–714. [Google Scholar] [CrossRef] [PubMed]
  20. Chekal, B.P.; Guinness, S.M.; Lillie, B.M.; McLaughlin, R.W.; Palmer, C.W.; Post, R.J.; Sieser, J.E.; Singer, R.A.; Sluggett, G.W.; Vaidyanathan, R.; et al. Development of an Efficient Pd-Catalyzed Coupling Process for Axitinib. Org. Process Res. Dev. 2013, 18, 266–274. [Google Scholar] [CrossRef]
  21. Klimešová, V.; Kočí, J.; Pour, M.; Stachel, J.; Waisser, K.; Kaustová, J. Synthesis and Preliminary Evaluation of Benzimidazole Derivatives as Antimicrobial Agents. Eur. J. Med. Chem. 2002, 37, 409–418. [Google Scholar] [CrossRef] [PubMed]
  22. Larsson, P.F.; Correa, A.; Carril, M.; Norrby, P.O.; Bolm, C. Copper-Catalyzed Cross-Couplings with Part-per-Million Catalyst Loadings. Angew. Chem. Int. Ed. 2009, 48, 5691. [Google Scholar] [CrossRef] [PubMed]
  23. Ueda, S.; Buchwald, S.L. Catalyst-Controlled Chemoselective Arylation of 2-Aminobenzimidazoles. Angew. Chem. Int. Ed. 2012, 51, 10364–10367. [Google Scholar] [CrossRef] [Green Version]
  24. Li, X.; Yuan, T.; Yang, Y.; Chen, J. Novel Copper/PEG-400 Catalyst Systems for Chemoselective S- and N-arylation of 2-Mercaptobenzothiazole. Tetrahedron 2014, 70, 9652–9660. [Google Scholar] [CrossRef]
  25. Duari, S.; Biswas, S.; Roy, A.; Maity, S.; Mishra, A.K.; Souza, A.R.; Elsharif, A.M.; Morgon, N.H.; Biswas, S. Regioselective N-Functionalization of Tautomerizable Heterocycles through Methyl Trifluoromethanesulfonate-Catalyzed Substitution of Alcohols and Alkyl Group Migrations. Adv. Synth. Catal. 2022, 364, 865–872. [Google Scholar] [CrossRef]
  26. Herrera Cano, N.; Ballari, M.S.; Lopez, A.G.; Santiago, A.N. New Synthesis and Biological Evaluation of Benzothiazole Derivates as Antifungal Agents. J. Agric. Food. Chem. 2015, 63, 3681–3686. [Google Scholar] [CrossRef] [PubMed]
  27. Ghaderi-Shekhi Abadi, P.; Rafiee, E.; Joshaghani, M. Pd-PVP-Fe (Palladium-Poly(N-vinylpyrrolidone)-iron) Catalyzed S-arylation of Thiols with Aryl Halides in Aqueous Media. Inorg. Chim. Acta. 2016, 451, 162–170. [Google Scholar] [CrossRef]
  28. Sikari, R.; Sinha, S.; Das, S.; Saha, A.; Chakraborty, G.; Mondal, R.; Paul, N.D. Achieving Nickel Catalyzed C-S Cross-Coupling under Mild Conditions Using Metal-Ligand Cooperativity. J. Org. Chem. 2019, 84, 4072–4085. [Google Scholar] [CrossRef]
  29. Feng, Y.-S.; Li, Y.-Y.; Tang, L.; Wu, W.; Xu, H.-J. Efficient Ligand-Free Copper-Catalyzed C-S Cross-Coupling of Thiols with Aryl Iodides Using KF/Al2O3 as Base. Tetrahedron Lett. 2010, 51, 2489–2492. [Google Scholar] [CrossRef]
  30. Wu, W.-Y.; Wang, J.-C.; Tsai, F.-Y. A Reusable FeCl3-6H2O/Cationic 2,2′-Bipyridyl Catalytic System for the Coupling of Aryl Iodides with Thiols in Water under Aerobic Conditionst. Green Chem. 2009, 11, 326–329. [Google Scholar] [CrossRef]
  31. Correa, A.; Carril, M.; Bolm, C. Iron-Catalyzed S-Arylation of Thiols with Aryl Iodides. Angew. Chem. Int. Ed. 2008, 47, 2880–2883. [Google Scholar] [CrossRef] [PubMed]
  32. Sokolova, A.S.; Yarovaya, O.I.; Shtro, A.A.; Borisova, M.S.; Morozova, E.A.; Tolstikova, T.G.; Zarubaev, V.V.; Salakhutdinov, N.F. Synthesis and Biological Activity of Heterocyclic Borneol Derivatives. Chem. Heterocycl. Compd. 2017, 53, 371–377. [Google Scholar] [CrossRef]
  33. Shi, L.; Liu, X.; Zhang, H.; Jiang, Y.; Ma, D. Synthesis of 2-Thio-Substituted Benzothiazoles via a Domino Condensation/S-Arylation/Heterocyclization Process. J. Org. Chem. 2011, 76, 4200–4204. [Google Scholar] [CrossRef] [PubMed]
  34. Kibriya, G.; Mondal, S.; Hajra, A. Visible-Light-Mediated Synthesis of Unsymmetrical Diaryl Sulfides via Oxidative Coupling of Arylhydrazine with Thiol. Org. Lett. 2018, 20, 7740–7743. [Google Scholar] [CrossRef]
  35. Ren, X.; Tang, S.; Li, L.; Li, J.; Liang, H.; Li, G.; Yang, G.; Li, H.; Yuan, B. Surfactant-Type Catalyst for Aerobic Oxidative Coupling of Hydrazine with Thiol in Water. J. Org. Chem. 2019, 84, 8683–8690. [Google Scholar] [CrossRef]
  36. Xu, H.J.; Zhao, Y.Q.; Feng, T.; Feng, Y.S. Chan-Lam-Type S-Arylation of Thiols with Boronic Acids at Room Temperature. J. Org. Chem. 2012, 77, 2878–2884. [Google Scholar] [CrossRef]
  37. Liu, X.; Dong, Z.B. Chemoselective Chan-Lam Coupling Reactions between Benzimidazoline-2-thiones and Arylboronic Acids. J. Org. Chem. 2019, 84, 11524–11532. [Google Scholar] [CrossRef]
  38. Bhowmik, A.; Yadav, M.; Fernandes, R.A. Room Temperature Nickel-Catalyzed Cross-Coupling of Aryl-Boronic Acids with Thiophenols: Synthesis of Diarylsulfides. Org. Biomol. Chem. 2020, 18, 2447–2458. [Google Scholar] [CrossRef]
  39. Quan, Z.J.; Ren, R.G.; Da, Y.X.; Zhang, Z.; Wang, X.C. Alkylation of SH-Heterocycles with Diethyl Phosphite Using Tetrachloroethylene as an Efficient Solvent. Heteroat. Chem. 2011, 22, 653–658. [Google Scholar] [CrossRef]
  40. Anan’Eva, K.V.; Rozhkova, N.K. Benzazolin-2-Thiones in the Michael Reaction. 2. Reaction of Benzothiazolin-and Benzoxazolin-2-Thiones with Acrylonitrile, Acrylamide, and Methyl Acrylate in the Presence of Basic Catalysts. Chem. Heterocycl. Compd. 1986, 22, 564–567. [Google Scholar] [CrossRef]
  41. Dong, Z.B.; Liu, X.; Bolm, C. Copper-Catalyzed C(sp2)-S Coupling Reactions for the Synthesis of Aryl Dithiocarbamates with Thiuram Disulfide Reagents. Org. Lett. 2017, 19, 5916–5919. [Google Scholar] [CrossRef] [PubMed]
  42. Dong, Z.B.; Balkenhohl, M.; Tan, E.; Knochel, P. Synthesis of Functionalized Diaryl Sulfides by Cobalt-Catalyzed Coupling between Arylzinc Pivalates and Diaryl Disulfides. Org. Lett. 2018, 20, 7581–7584. [Google Scholar] [CrossRef] [PubMed]
  43. Gao, M.Y.; Li, J.H.; Zhang, S.B.; Chen, L.J.; Li, Y.S.; Dong, Z.B. A Mild Synthesis of 2-Substituted Benzothiazoles via Nickel-Catalyzed Intramolecular Oxidative C-H Functionalization. J. Org. Chem. 2020, 85, 493–500. [Google Scholar] [CrossRef] [PubMed]
  44. Wang, D.; Peng, H.Y.; Yang, M.M.; Hao, E.J.; Li, Y.S.; Dong, Z.B. Cs2CO3-Promoted Hydrothiolation of Alkynes with Aryl Thioureas: Stereoselective Synthesis of (Z)-Vinyl Sulfides. J. Org. Chem. 2021, 86, 8457–8464. [Google Scholar] [CrossRef] [PubMed]
  45. Liu, X.; Liu, M.; Xu, W.; Zeng, M.T.; Zhu, H.; Chang, C.Z.; Dong, Z.B. An Environmentally Benign and Efficient Synthesis of Substituted Benzothiazole-2-thiols, Benzoxazole-2-thiols, and Benzimidazoline-2-thiones in Water. Green Chem. 2017, 19, 5591–5598. [Google Scholar] [CrossRef]
Catalysts 13 00658 g001 550
Figure 1. Representative biologically active compounds containing C-N/C-S bonds.
Figure 1. Representative biologically active compounds containing C-N/C-S bonds.
Catalysts 13 00658 g001
Catalysts 13 00658 sch001 550
Scheme 1. Previous strategies for the synthesis of C-N/C-S bonds [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38].
Scheme 1. Previous strategies for the synthesis of C-N/C-S bonds [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38].
Catalysts 13 00658 sch001
Catalysts 13 00658 sch002 550
Scheme 2. Selective formation of C-N/C-S bonds in one-pot strategy [45].
Scheme 2. Selective formation of C-N/C-S bonds in one-pot strategy [45].
Catalysts 13 00658 sch002
Catalysts 13 00658 g002 550
Figure 2. X-ray crystallography of 3ai.
Figure 2. X-ray crystallography of 3ai.
Catalysts 13 00658 g002
Catalysts 13 00658 g003 550
Figure 3. X-ray crystallography of by-product 5ag’.
Figure 3. X-ray crystallography of by-product 5ag’.
Catalysts 13 00658 g003
Table
Table 1. Optimization of the reaction conditions a.
Table 1. Optimization of the reaction conditions a.
Catalysts 13 00658 i001
EntryCat.BaseTemp. (°C)SolventYield b (%)
1CuIEt3N (2.0 eq.)60EtOH19
2CuOEt3N (2.0 eq.)60EtOH17
3CuBr2Et3N (2.0 eq.)60EtOH15
4FeCl3Et3N (2.0 eq.)60EtOH<10
5CuIEt3N (2.0 eq.)60DMF48
6-Et3N (2.0 eq.)60DMF68
7-Na2CO3 (2.0 eq.)60DMF53
8-NaHCO3 (2.0 eq.)60DMF52
9-Et2NH (2.0 eq.)60DMF60
10-Et3N (2.0 eq.)80DMF85
11-Et3N (2.0 eq.)100DMF84
12-Et3N (2.0 eq.)110DMF80
13-Et3N (1.0 eq.)80DMF70
14-Et3N (3.0 eq.)80DMF72
15-Et3N (2.0 eq.)80H2O36
16-Et3N (2.0 eq.)80DMSO79
a Reaction conditions: Step I: 1a (0.5 mmol), tetramethylthiuram disulfide (TMTD, 0.3 mmol), solvent (2 mL), stirred in a sealed tube for 3 h. Step II: 2a (1.0 mmol), catalyst (2 eq.), stirred in a sealed tube for 6 h. b Isolated yield.
Table
Table 2. One-pot synthesis of benzoxazole-substituted ester compounds a,b.
Table 2. One-pot synthesis of benzoxazole-substituted ester compounds a,b.
Catalysts 13 00658 i002
Catalysts 13 00658 i003
3aa, 85%		Catalysts 13 00658 i004
3ab, 84%		Catalysts 13 00658 i005
3ac, 82%		Catalysts 13 00658 i006
3ad, 78%
Catalysts 13 00658 i007
3ae, 88%		Catalysts 13 00658 i008
3af, 53%		Catalysts 13 00658 i009
3ag, 70%		Catalysts 13 00658 i010
3ah, 28%
Catalysts 13 00658 i011
3ai, 86%		Catalysts 13 00658 i012
3aj, 29%		Catalysts 13 00658 i013
3ak, 89%		Catalysts 13 00658 i014
3al, 73%
Catalysts 13 00658 i015
3am, 84%		Catalysts 13 00658 i016
3an, 70%		Catalysts 13 00658 i017
3ao, 89%		Catalysts 13 00658 i018
3ap, 69%
Catalysts 13 00658 i019
3aq, 70%		Catalysts 13 00658 i020
3ar, 36%		Catalysts 13 00658 i021
3as, 80%		Catalysts 13 00658 i022
3at, 88%
Catalysts 13 00658 i023
3au, 56%		Catalysts 13 00658 i024
3av, 87%
a Reaction conditions: Step I: 1 (0.5 mmol), tetramethylthiuram disulfide (TMTD, 0.3 mmol), DMF (2 mL), 80 °C, stirred in a sealed tube for 3 h. Step II: 2 (1.0 mmol), Et3N (2.0 eq.), 80 °C, stirred in a sealed tube for 6 h. b Isolated yield.
Table
Table 3. One-pot synthesis of benzothiazole-substituted ester compounds a,b.
Table 3. One-pot synthesis of benzothiazole-substituted ester compounds a,b.
Catalysts 13 00658 i025
Catalysts 13 00658 i026
5aa, 66%		Catalysts 13 00658 i027
5ab, 71%		Catalysts 13 00658 i028
5ac, 62%
Catalysts 13 00658 i029
5ad, 44%
Catalysts 13 00658 i030
5ag, 70%		Catalysts 13 00658 i031
5ae, 61%		Catalysts 13 00658 i032
5af, 62%
a Reaction conditions: Step I: 4 (0.5 mmol), tetramethylthiuram disulfide (TMTD, 0.3 mmol), DMF (2 mL), 80 °C, stirred in a sealed tube for 3 h. Step II: 2 (1.0 mmol), Et3N (2.0 eq.), 80 °C, stirred in a sealed tube for 6 h. b Isolated yield.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gong, Z.-Y.; Yang, C.-L.; Wang, D.; Huang, L.; Dong, Z.-B. One-Pot Synthesis of Benzoxazole/Benzothiazole-Substituted Esters by Michael Addition: A Selective Construction of C-N/C-S Bonds. Catalysts 2023, 13, 658. https://doi.org/10.3390/catal13040658

AMA Style

Gong Z-Y, Yang C-L, Wang D, Huang L, Dong Z-B. One-Pot Synthesis of Benzoxazole/Benzothiazole-Substituted Esters by Michael Addition: A Selective Construction of C-N/C-S Bonds. Catalysts. 2023; 13(4):658. https://doi.org/10.3390/catal13040658

Chicago/Turabian Style

Gong, Zhi-Ying, Cheng-Li Yang, Dan Wang, Lang Huang, and Zhi-Bing Dong. 2023. "One-Pot Synthesis of Benzoxazole/Benzothiazole-Substituted Esters by Michael Addition: A Selective Construction of C-N/C-S Bonds" Catalysts 13, no. 4: 658. https://doi.org/10.3390/catal13040658

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop